Adenosine receptors and Huntington's disease: implications for pathogenesis and therapeutics
- 1 June 2003
- journal article
- review article
- Published by Elsevier in The Lancet Neurology
- Vol. 2 (6) , 366-374
Abstract
No abstract availableKeywords
This publication has 130 references indexed in Scilit:
- Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutaminesNature Neuroscience, 2002
- Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damageNature, 2001
- Loss of normal huntingtin function: new developments in Huntington's disease researchTrends in Neurosciences, 2001
- Restoration of Cognitive and Motor Functions by Ciliary Neurotrophic Factor in a Primate Model of Huntington's DiseaseHuman Gene Therapy, 2000
- Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's diseaseTrends in Pharmacological Sciences, 1997
- Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic MiceCell, 1996
- Opposite effects of cyclohexyladenosine and theophylline on hypoxic damage in cultured neuronsNeuroscience Letters, 1994
- Acute dyskinesias in young asthmatics treated with theophyllinePediatric Neurology, 1991
- A cloned G protein-coupled protein with a distribution restricted to striatal medium-sized neurons. Possible relationship with D1 dopamine receptorBrain Research, 1990
- Cerebral ischemia in gerbils: Postischemic administration of cyclohexyl adenosine and 8-sulfophenyl-theophyllineJournal of Molecular Neuroscience, 1990